IRM
Overvalued by 132.7% based on the discounted cash flow analysis.
Market cap | $22.64 Billion |
---|---|
Enterprise Value | $34.35 Billion |
Dividend Yield | $2.5346 (3.28%) |
Earnings per Share | $0.63 |
Beta | 0.0 |
Outstanding Shares | 293,096,117 |
Avg 30 Day Volume | 1,070,509 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 122.91 |
---|---|
PEG | -160.17 |
Price to Sales | 4.28 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 6.27 |
Enterprise Value to EBIT | 30.95 |
Enterprise Value to Net Income | 186 |
Total Debt to Enterprise | 0.35 |
Debt to Equity | 56.38 |
No data
No data